Givlaari (givosiran), first treatment for acute hepatic porphyria
5 Febbraio 2020
The EU Medicines Agency has recommended granting a marketing authorisation in the European Union (EU) for Givlaari (givosiran), the first treatment for acute hepatic porphyria (AHP) in adults
